THE FIRST DERMAL FILLER FAMILY offering a COMPLETE CUSTOMIZED SOLUTION for patients seeking LONGER LASTING RESULTS
TM
ELLANSÉ FAMILY TM The Ellansé Family is scientifically designed to provide optimal safety, biocompatibility, durability options, efficacy and ease of use in soft tissue augmentation. It is TM the first dermal filler family with the unique feature of Tunable Longevity. Ellansé is further differentiated by the characteristics of Immediate- & Sustained TM Performance and Total Bioresorbability (STAT Technology ).
Break-up of % Patients with Improvement for EllanséTM-M 100%
EllanséTM Family Longevity Options Patients % with improvements
0,0%
90% 10,0% 20,0%
80% 20,0%
70% 55,0%
60%
45,0%
50% 60,0%
40%
45,0%
30% 20%
35,0%
35,0%
10%
15,0% 10,0%
3 months
6 months Improved
COMPOSITION All members of the EllanséTM Family are composed of unique totally smooth and spherical shaped Polycaprolactone microspheres, homogeneously suspended in a tailor-made aqueous Carboxy-methylcellulose gel-carrier.
9 months Much Improved
12 months Very Much Improved
CLINICALLY PROVEN Results from extensive safety studies conducted on the implant formulation, including in-vitro, pre-clinical and clinical testing and additional literature studies demonstrate that the entire EllanséTM dermal filler family is safe, biocompatible and shows excellent performance characteristics.
AQTIS Medical
www.ellanse.com
Innovative Bioresorbable Solutions
AOTIS Medical BV - Yalelaan 44 - 3584 CM - Utrecht - The Netherlands - Tel. +31 30 253 1901 - www.aqtismedical.com
Wigmore Medical, 23 Wigmore Street, London, W1U 1PL Tel: 020 7491 2782 Email: customerservices@wigmoremedical.com Web: www.wigmoremedical.com